Founder President & CEO
Dr. Tandon is the President and CEO of NEOBIOTECHNOLOGIES, a leading antibody company based in Silicon Valley, California. His passion for antibodies is evident in all he does and has been a pioneer in the antibody industry for the past four decades.
Dr. Tandon was born in India in 1953. He received his MSc in Biochemistry from Lucknow University in 1975 and his PhD in Biochemistry/Reproductive Immunology from AIIMS in 1982. After completing his PhD, he moved to San Antonio, Texas, where he worked in academia for seven years in the area of breast cancer prognosis. His contributions to this field led to the development of Herceptin, a drug that is still marketed today by Genentech.
In 1991, Dr. Tandon moved to California to become the head of R&D at a biotechnology company. Two years later, in 1993, he founded his own biotechnology company, NEOMARKERS. Dr. Tandon managed this company successfully for 9 years, after which it was acquired by Thermo-Fisher. Since then, he has founded and sold several biotech companies and has been a leader in the antibody industry for the past 30 years. He is a role model for aspiring scientists and entrepreneurs, and his work has helped to save countless lives. He is well known in the antibody industry and has been given the nickname ‘MAbMan’ – The Monoclonal Antibody Man.
Currently, Dr. Tandon is the President and CEO of NEOBIOTECHNOLOGIES, a premier antibody company based in Silicon Valley, California. NEOBIOTECHNOLOGIES holds 10,000+ monoclonal antibodies of the highest quality and was founded in 2013, marking a decade of its existence this year.